Dr. Taewoong Choi
Overview
Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients.
Dr. Choi is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 25 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
Additional Areas of Focus
Dr. Choi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
University Of North Carolina At Chapel Hill
Natalie Grover is an Oncologist and a Hematologist in Chapel Hill, North Carolina. Dr. Grover is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Marginal Zone Lymphoma (MZL), Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Grover is currently accepting new patients.
Duke Blood Cancer Center
I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists. Dr. Stefanovic is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Waldenstrom Macroglobulinemia, Diffuse Large B-Cell Lymphoma (DLBCL), Marginal Zone Lymphoma (MZL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.
The Moses H Cone Memorial Hospital Operating Corporation
Mohamed Mohamed is a Hematologist and an Oncologist in Greensboro, North Carolina. Dr. Mohamed is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and EGFR Positive Lung Cancer. Dr. Mohamed is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Choi isDistinguished. Learn about Multiple Myeloma.
- Smoldering Multiple MyelomaDr. Choi isDistinguished. Learn about Smoldering Multiple Myeloma.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Choi isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Angioimmunoblastic T-cell Lymphoma
- Bone Marrow TransplantDr. Choi isAdvanced. Learn about Bone Marrow Transplant.
- Castleman DiseaseDr. Choi isAdvanced. Learn about Castleman Disease.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Choi isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Choi isExperienced. Learn about Acute Mountain Sickness.
- Acute Promyelocytic LeukemiaDr. Choi isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Choi isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Choi isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Aplastic AnemiaDr. Choi isExperienced. Learn about Aplastic Anemia.